ENvue Medical, Inc. Income Statement
FEED|11 years of annual SEC 10-K data (FY2015-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 11 fiscal years. All figures from audited SEC 10-K filings.
ENvue Medical, Inc. reported $3M in revenue and $4M in net loss for FY2025. Revenue has grown at a 28.8% compound annual rate over the past 10 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.6M | $2.3M | $752.0K | $1.7M | $623.0K | $530.0K | $318.0K | $239.0K | $229.0K | $147.0K | $203.0K |
| Cost of Revenue | $1.1M | $746.0K | $585.0K | $925.0K | $409.0K | $249.0K | $158.0K | $88.0K | $88.0K | $49.0K | $93.0K |
| Gross Profit | $1.5M | $1.5M | $167.0K | $770.0K | $214.0K | $281.0K | $160.0K | $151.0K | $141.0K | $98.0K | $110.0K |
| SG&A Expense | $3.5M | $3.9M | $3.9M | $5.1M | $3.8M | $3.8M | $2.6M | $2.1M | $1.4M | $746.0K | $589.0K |
| R&D Expense | $909.0K | $185.0K | $283.0K | $293.0K | $171.0K | $514.0K | $614.0K | $693.0K | $584.0K | $399.0K | $431.0K |
| Operating Income | -$3.6M | -$3.4M | -$5.0M | -$5.7M | -$4.7M | -$5.2M | -$4.3M | -$3.1M | -$2.3M | -$1.4M | -$1.2M |
| Interest Expense | - | $135.0K | $347.0K | $347.0K | $147.0K | $15.0K | $15.0K | $37.0K | $37.0K | $65.0K | $372.0K |
| Income Tax | $19.0K | $29.0K | $35.0K | $32.0K | $15.0K | -$17.0K | -$127.0K | $38.0K | $117.0K | $28.0K | $49.0K |
| Net Income | -$3.7M | -$3.7M | -$5.4M | -$14.3M | -$4.3M | -$5.8M | -$4.2M | -$5.0M | -$2.8M | -$2.9M | -$2.6M |
| EPS (Basic) | -$137.30 | -$23.32 | -$3.84 | -$11.35 | - | - | - | - | - | - | - |
| EPS (Diluted) | -$137.30 | -$23.32 | -$3.84 | - | -$0.42 | -$0.83 | -$0.64 | -$1.17 | -$0.62 | -$0.82 | -$17.08 |
| Shares Outstanding | 37.9K | 186.0K | 1.6M | 1.4M | 19.9M | 4.2M | 3.8M | 3.9M | 2.6M | 2.6M | 163.6K |
| Gross Margin | 59.0% | 67.3% | 22.2% | 45.4% | 34.4% | 53.0% | 50.3% | 63.2% | 61.6% | 66.7% | 54.2% |
| Operating Margin | -140.0% | -150.5% | -666.5% | -335.3% | -757.5% | -971.9% | -1353.1% | -1293.3% | -1011.4% | -968.7% | -596.5% |
| Profit Margin | -144.8% | -162.5% | -724.5% | -842.6% | -694.4% | -1093.2% | -1306.3% | -2077.4% | -1236.2% | -1961.9% | -1303.9% |